title: Inhaled iloprost plus levosimendan to decompensate right heart failure due to chronic thromboembolic pulmonary hypertension.
authors.forename: G
authors.initials: G
authors.lastname: Pitsiou
authors.forename: A
authors.initials: A
authors.lastname: Paspala
authors.forename: V
authors.initials: V
authors.lastname: Bagalas
authors.forename: A K
authors.initials: AK
authors.lastname: Boutou
authors.forename: I
authors.initials: I
authors.lastname: Stanopoulos
mesh_terms: D000280:Administration, Inhalation; D003422:Critical Care; D004232:Diuretics / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D006976:Hypertension, Pulmonary / Q000150:complications*; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan; D013923:Thromboembolism / Q000150:complications*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018497:Ventricular Dysfunction, Right / Q000188:drug therapy
chemical_list: D004232:Diuretics; D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan; D005665:Furosemide; D016285:Iloprost